Motion-Tracking of Heart MRI Scans Could Predict Stroke Risk
By MedImaging International staff writers Posted on 05 May 2015 |
Researchers from the Johns Hopkins School of Medicine (Baltimore, MD, USA) have successfully used motion tracking software to analyze changes in cardiac muscle movement and predict the likelihood of stroke risk in patients with atrial fibrillation.
The new imaging technique uses standard Magnetic Resonance Imaging (MRI) scans together with motion-tracking software to analyze altered function of heart muscle in the left atrium. The study was published on April 27, 2015, in the Journal of the American Heart Association, and could help researchers build more accurate models to predict strokes, and therapy strategies, and prevent unnecessary long-term prescription of blood thinning medicines such as warfarin.
The study looked at records of 169 patients, ages 49–69, with atrial fibrillation, 18 of whom had suffered from strokes. The patients had cardiac MRI exams, and underwent minimally-invasive ablation of the heart tissue that triggered the fibrillation. The researchers used the motion tracking software to compare images of the hearts of patients who had suffered strokes with those who had not, and found several marked differences.
Lead investigator and heart rhythm specialist Hiroshi Ashikaga, MD, PhD, said, “Our research suggests that certain features of the heart’s upper left chamber that are easily seen on heart MRI could be the smoking gun we need to tell apart low-risk from high-risk patients.”
Related Links:
Johns Hopkins School of Medicine
The new imaging technique uses standard Magnetic Resonance Imaging (MRI) scans together with motion-tracking software to analyze altered function of heart muscle in the left atrium. The study was published on April 27, 2015, in the Journal of the American Heart Association, and could help researchers build more accurate models to predict strokes, and therapy strategies, and prevent unnecessary long-term prescription of blood thinning medicines such as warfarin.
The study looked at records of 169 patients, ages 49–69, with atrial fibrillation, 18 of whom had suffered from strokes. The patients had cardiac MRI exams, and underwent minimally-invasive ablation of the heart tissue that triggered the fibrillation. The researchers used the motion tracking software to compare images of the hearts of patients who had suffered strokes with those who had not, and found several marked differences.
Lead investigator and heart rhythm specialist Hiroshi Ashikaga, MD, PhD, said, “Our research suggests that certain features of the heart’s upper left chamber that are easily seen on heart MRI could be the smoking gun we need to tell apart low-risk from high-risk patients.”
Related Links:
Johns Hopkins School of Medicine
Latest MRI News
- Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer